Brian Mulnix

Brian Mulnix is an accomplished executive in the pharmaceutical industry, currently serving as General Manager for Biologics North America at Dr. Reddy's Laboratories since August 2023, where responsibilities include building the commercial organization for the US market across various functions. Previously at LEO Pharma from 2017 to 2023, Mulnix held the role of VP for Business Development & New Product Strategy, leading significant acquisitions such as Timber Pharmaceuticals, and also served as VP for US Marketing, directing the launch of Adbry®. Notable positions before that include VP of Commercial Strategy & Business Development at Sun Pharma, VP of US Marketing at Galderma, and various leadership roles at Pfizer where significant contributions included developing global strategies for Xeljanz® and Enbrel®. Mulnix's career began at Merck, and educational achievements include an MBA in Marketing and Finance from the University of Michigan and a Bachelor of Science in Economics from the University of Minnesota.